Growth Arrest-specific 1 Inhibits Keap1/Nrf2 Signaling Transduction in the Activation of the Ferroptosis Program in

Rongfeng Dai1, Yu Qian1, Siqi Liu1

  • 1Department of Endocrinology, the Third People's Hospital of Changzhou, 213001 Changzhou, Jiangsu, China.

Abstract

Insights

Growth arrest-specific 1 (GAS1) promotes ferroptosis in diabetic retinopathy (DR) by inhibiting Keap1/Nrf2 signaling. Reducing GAS1 protects retinal Müller cells from high glucose-induced damage, offering a potential therapeutic target for DR.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Ophthalmology

Background:

  • Diabetic retinopathy (DR) is a microvascular complication of diabetes.
  • Growth arrest-specific 1 (GAS1) is implicated in high glucose-induced retinal Müller cell death via ferroptosis.
  • The precise role of GAS1 in DR pathogenesis remains unclear.

Purpose of the Study:

  • To investigate the role and mechanism of GAS1 in DR.
  • To explore GAS1-mediated ferroptosis in retinal Müller cells under high glucose conditions.

Main Methods:

  • Transcriptome sequencing and bioinformatic analyses (KEGG, GO) identified GAS1.
  • Assays included CCK-8, flow cytometry, and commercial kits to measure cell viability, apoptosis, lipid peroxidation, Fe2+, and oxidative stress.
  • Gene expression analysis utilized qRT-PCR and Western blotting for GAS1, Nrf2, and Keap1.

Main Results:

  • High glucose (HG) reduced Müller cell viability and glutathione (GSH) while increasing apoptosis, lipid ROS, MDA, and Fe2+.
  • HG upregulated GAS1, Keap1, and total Nrf2, but downregulated nuclear Nrf2.
  • GAS1 knockdown improved viability and GSH, reduced apoptosis and oxidative stress markers, and increased nuclear Nrf2, while GAS1 overexpression had opposite effects. Nrf2 silencing reversed GAS1 overexpression effects.

Conclusions:

  • GAS1 inhibits Keap1/Nrf2 signaling, promoting ferroptosis in retinal Müller cells.
  • Targeting GAS1 may offer a novel therapeutic strategy for diabetic retinopathy.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...